Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen F. Mahoney Insider Profile
4 Followers
Stephen F. Mahoney, President & COO at Kiniksa Pharmaceuticals, holds 21.40K shares in Viridian Therapeutics (Ticker: VRDN), holds 17.26K shares in Dianthus Therapeutics (Ticker: DNTH), holds 116.19K shares in Kiniksa Pharmaceuticals (Ticker: KNSA). Most recently, Stephen F. Mahoney Bought ― shares of Viridian Therapeutics on Sep 30, 2024 for an estimated value of 499.26K.
Stephen F. Mahoney Kiniksa Pharmaceuticals (KNSA)President & COO
Kiniksa Pharmaceuticals (KNSA)
President & COO
Ranked #35,926 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+30.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen F. Mahoney holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 20, 2021 - Sep 20, 2022
Return:+77.80%
The most profitable trade made by Stephen F. Mahoney
Stephen F. Mahoney's Trading History
Kiniksa Pharmaceuticals
May 29, 2018
President & COO
Uninformative Buy
―
$2.32M
Dianthus Therapeutics
Dec 02, 2022
Chief Financial and Operating Officer
Uninformative Buy
2.82K
$395.35K
Viridian Therapeutics
Sep 30, 2024
President & CEO, Director
Informative Buy
499.26K
$413.23K
List of latest transactions for each holding click on a transaction to see Stephen F. Mahoney's performance on stock
You May Also Like
Stephen F. Mahoney insider profile FAQ
What is the percentage of profitable transactions made by Stephen F. Mahoney?
The percentage of profitable transactions made by Stephen F. Mahoney is 50%.
What is the average return per transaction made by Stephen F. Mahoney?
The average return per transaction made by Stephen F. Mahoney is 30.70%.
What stocks does Stephen F. Mahoney hold?
Stephen F. Mahoney holds: KNSA, DNTH, VRDN stocks.
What was Stephen F. Mahoney’s latest transaction?
Stephen F. Mahoney latest transaction was an Informative Buy of $499.26K.
What was Stephen F. Mahoney's most profitable transaction?
Stephen F. Mahoney’s most profitable transaction was an Informative Sell of DNTH stock on September 20, 2021. The return on the trade was 77.80%.
What is Stephen F. Mahoney's role in Kiniksa Pharmaceuticals?
Stephen F. Mahoney's role in Kiniksa Pharmaceuticals is President & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.